http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114010707-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-487 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-236 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2021-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114010707-B |
| titleOfInvention | A kind of pharmaceutical composition for treating pulmonary heart disease and its preparation method and use |
| abstract | The invention provides a pharmaceutical composition for treating pulmonary heart disease, which is prepared from the following raw materials by weight: 20-30 parts of Astragalus, 12-18 parts of Tinglizi, 5-10 parts of Bakuchi, and 12-12 parts of Chuanxiong 18 servings, 5-10 servings of Alisma, 5-10 servings of Campanulaceae, 1-5 servings of jujube. The composition of the invention has reasonable compatibility, all the medicines have the functions of benefiting the temperature and kidney, purging the lung and relieving asthma, and have excellent curative effect on the syndrome of deficiency of lung and kidney qi in the remission stage of chronic pulmonary heart disease, can effectively improve the right heart failure in the remission stage of chronic pulmonary heart disease, and improve blood circulation. Oxygen partial pressure, reducing plasma fibrinogen content, reducing blood viscosity, improving myocardial hypertrophy, strengthening the heart, diuretic and improving pulmonary edema, improving vasomotor function, and have a good clinical application prospect. |
| priorityDate | 2021-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 80.